Abstract:Event Abstract Back to Event Irreversibly skewed development of B cells towards terminal stages during HIV-1 infection and resulted in their functional impairment Jingjing Yan1, Chao Qiu1, 2, Liangzhu Li1, 2, Chenli Qiu1, Jun Sun1, Jianqing Xu1, 2, 3* and Xiaoyan Zhang1, 2, 3* 1 Shanghai Public Health Clinical Center, Fudan University, Shanghai, China 2 Institutes of Biomedical Sciences, Fudan University, Shanghai, China 3 Key laboratory of Medical Molecules Virology of Ministry of Education/Health, Fudan University, Shanghai, China Background: HIV-1 infection results in the abnormalities of B cells. Here we defined the skewed differentiation of B cells and their functionality in HIV-1 chronically infected subjects. Methods: We employed flow cytometry to determine the differences in the frequencies and the phenotypes of B-cell subpopulations among32 HIV-1 viremic subjects naïve to antiretroviral therapy (ART), 34 ART successfully treated patients and 12 HIV-seronegative donors. Furthermore, HIV Env specific or influenza HA specific antibody secreting cells (ASCs) were quantified. Results: CD19+ B-cell counts were significantly less in the chronically HIV-1 infected than the HIV-seronegative group (p=0.05), which was manifested in naïve, immature, resting memory B cells and plasmablasts(p<0.01, p=0.02, p=0.02 and p<0.01, respectively); In contrast, the frequencies of tissue-like memory B cells, defined as dysfunctional B cells, was elevated in chronically HIV infected subjects (p<0.01). Activation markers CD38 and CD95 expressing B cells increased in chronically HIV infected subjects (p<0.01 and p<0.01, respectively) whereas Bcl-2 decreased comparing to HIV-seronegative subjects (p<0.001). Successful ART only partially restored the skewed development of B cells. Furthermore, B cells from HIV infected subjects showed impaired responses to influenza HA (p=0.028) and the suppression of HIV replication by ART led to the decreased HIV-specific ASCs (p<0.01). Conclusions: HIV infection resulted in the skewed differentiation of B-cell subpopulations towards terminal stage, which was accompanied by a functional impairment; ART only partially restored the abnormality. It remains a challenge to revoke B cell functionalities. Acknowledgements This work was supported by the 973 Program (2012CB519005), National Natural Science Foundation of China (81171553, 812111038, and 31000413) and Chinese National Grand Program on Key Infectious Disease Control and Prevention (2012ZX10001-006, 2013ZX10001006). Keywords: HIV-1, B cells, phenotype, Founctionality, Art Conference: 15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013. Presentation Type: Abstract Topic: Host-pathogen interactions Citation: Yan J, Qiu C, Li L, Qiu C, Sun J, Xu J and Zhang X (2013). Irreversibly skewed development of B cells towards terminal stages during HIV-1 infection and resulted in their functional impairment. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.00461 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 12 Apr 2013; Published Online: 22 Aug 2013. * Correspondence: Prof. Jianqing Xu, Shanghai Public Health Clinical Center, Fudan University, Shanghai, Shanghai, China, jianqingxu2008@gmail.com Prof. Xiaoyan Zhang, Shanghai Public Health Clinical Center, Fudan University, Shanghai, Shanghai, China, zhang_xycn2002@yahoo.com.cn Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Jingjing Yan Chao Qiu Liangzhu Li Chenli Qiu Jun Sun Jianqing Xu Xiaoyan Zhang Google Jingjing Yan Chao Qiu Liangzhu Li Chenli Qiu Jun Sun Jianqing Xu Xiaoyan Zhang Google Scholar Jingjing Yan Chao Qiu Liangzhu Li Chenli Qiu Jun Sun Jianqing Xu Xiaoyan Zhang PubMed Jingjing Yan Chao Qiu Liangzhu Li Chenli Qiu Jun Sun Jianqing Xu Xiaoyan Zhang Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.

Analysis of B cell phenotype and the restoration of antiretroviral therapy in chronic human immunodeficiency virus type 1 infection

Immune reconstitution in HIV-1 infected individuals with long-term highly active antiretroviral therapy

Study of T Cell Subsets and IL-7 Protein Expression in HIV-1-infected Patients after 7 Years HAART

Analysis of CD44 and CD95 Expression on CD4+ T Lymphocyte of HIV-1 Infected Subjects after Effective HAART

The investigation of CD4+T-cell functions in primary HIV infection with antiretroviral therapy

Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection

Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33⁺CD11b⁺HLA-DR⁺ Cells: A Cross-Sectional Study

Effect of Long-Term Highly Active Antiretroviral Therapy on Abnormal Immune Activation and Immune Reconstruction in HIV-1 Infected Individuals

Irreversibly Skewed Development of B Cells Towards Terminal Stages During HIV-1 Infection and Resulted in Their Functional Impairment

The Impact of Highly Active Antiretroviral Treatment on the Blood Profiles of Patients with Acquired Immune Deficiency Syndrome

Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients

Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression

Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs

Determinants of CD4+ T Cell Recovery During Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV-1 DNA.

Increased Expression of BCL11B and Its Recruited Chromatin Remodeling Factors During Highly Active Antiretroviral Therapy Synergistically Represses the Transcription of Human Immunodeficiency Virus Type 1 and is Associated with Residual Immune Activation

Analysis of the dysregulation between regulatory B and T cells (Breg and Treg) in human immunodeficiency virus (HIV)-infected patients

Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

Characteristics of blood immune cell profile and their correlation with disease progression in patients infected with HIV-1

Altered T-Cell Subsets Are Associated with Dysregulated Cytokine Secretion of CD4+ T Cells During HIV Infection

Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation

Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways